Synlogic, Inc. (SYBX) Covered Calls
There are no covered calls available for Synlogic, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase I/IIa clinical trial to treat phenylketonuria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.
| Top 10 Open Interest For May 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | IWM covered calls | 6. | EEM covered calls | 1. | WOLF covered calls | |
| 2. | HYG covered calls | 7. | KWEB covered calls | 2. | FSLY covered calls | |
| 3. | QQQ covered calls | 8. | SLV covered calls | 3. | ENVX covered calls | |
| 4. | SPY covered calls | 9. | TSLA covered calls | 4. | NOVA covered calls | |
| 5. | FXI covered calls | 10. | NVDA covered calls | 5. | COIN covered calls | |
Want more examples? SYBT Covered Calls | SYF Covered Calls
